{
    "organizations": [],
    "uuid": "141f4626b7dfae3fd62ba9d69498dc8fab97044f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-announces-availabilit/brief-novo-nordisk-announces-availability-of-new-diabetes-medications-at-pharmacies-across-u-s-idUSFWN1PV0UD",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk Announces Availability Of New Diabetes Medications At Pharmacies Across U.S.",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "  Updated 9 minutes ago BRIEF-Novo Nordisk Announces Availability Of New Diabetes Medications At Pharmacies Across U.S. Reuters Staff 1 Min Read \nFeb 5 (Reuters) - Novo Nordisk A/S: \n* NOVO NORDISK - ANNOUNCED AVAILABILITY OF NEW DIABETES MEDICATIONS, OZEMPIC INJECTION 0.5 MG OR 1 MG AND FIASP 100 UNITS/ML AT PHARMACIES ACROSS U.S. Source text for Eikon:  ",
    "published": "2018-02-05T15:40:00.000+02:00",
    "crawled": "2018-02-05T15:55:13.125+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "nordisk",
        "announces",
        "availability",
        "new",
        "diabetes",
        "medication",
        "pharmacy",
        "across",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "novo",
        "nordisk",
        "novo",
        "nordisk",
        "announced",
        "availability",
        "new",
        "diabetes",
        "medication",
        "ozempic",
        "injection",
        "mg",
        "mg",
        "fiasp",
        "pharmacy",
        "across",
        "source",
        "text",
        "eikon"
    ]
}